Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of estradiol-progestin vaginal rings for primary dysmenorrhea
2012-002449-40Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of nomegestrol, estradiol and etonogestrel in primary dysmenorrhea (PD) (5 arms), sponsored by Merck & Co. Started Aug 2012; status: completed.
02
Drugs
nomegestrolestradioletonogestrel
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2012-002449-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002449-40.